Publication date: Nov 26, 2019
The purpose of the clinical trial is to test how Simvastatin (80mg/day) may decrease attacks and progression of disease in patients with multiple sclerosis under disease modifying therapy (DMTs)
|disease||MESH||Relapsing-Remitting Multiple Sclerosis|
- The Effect of Repetitive Transcranial Magnetic Stimulation on Spasticity in Patients with Multiple Sclerosis.
- MS & Spasticity: Dr. Ben Thrower – October 2019